ArticleJournal of hepatocellular carcinoma2025

Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network.

David Cosgrove et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.